DOĞAN, İ. Et Al. 2022. Evaluation of clinicopathological features determining treatment response in patients with ALK mutant NSCLC. MEDICINE , vol.101, no.34 .

DOĞAN, İ., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... DEMİRKAZIK, A.(2022). Evaluation of clinicopathological features determining treatment response in patients with ALK mutant NSCLC. MEDICINE , vol.101, no.34.

DOĞAN, İzzet Et Al. "Evaluation of clinicopathological features determining treatment response in patients with ALK mutant NSCLC," MEDICINE , vol.101, no.34, 2022

DOĞAN, İzzet Et Al. "Evaluation of clinicopathological features determining treatment response in patients with ALK mutant NSCLC." MEDICINE , vol.101, no.34, 2022

DOĞAN, İ. Et Al. (2022) . "Evaluation of clinicopathological features determining treatment response in patients with ALK mutant NSCLC." MEDICINE , vol.101, no.34.

@article{article, author={İzzet DOĞAN Et Al. }, title={Evaluation of clinicopathological features determining treatment response in patients with ALK mutant NSCLC}, journal={MEDICINE}, year=2022}